Evidence map›Paper›PMID 24470708›Full record

Trial reportSleep2014

Acute sleep deprivation increases serum levels of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in healthy young men.

Christian Benedict, Jonathan Cedernaes, Vilmantas Giedraitis, Emil K Nilsson, Pleunie S Hogenkamp, Evelina Vågesjö, Sara Massena, Ulrika Pettersson, Gustaf Christoffersson, Mia Phillipson and 4 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Sleep, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. The Role of GDNF and NSE in Attention-deficit/Hyperactivity Disorder: The Relationship with Sleep and Eating.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Christian BenedictDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Jonathan CedernaesDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Vilmantas GiedraitisMolecular Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Emil K NilssonDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Pleunie S HogenkampDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Evelina VågesjöDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Sara MassenaDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Ulrika PetterssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Gustaf ChristofferssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Mia PhillipsonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Jan-Erik BromanDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Lars LannfeltMolecular Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Henrik ZetterbergClinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden ; UCL Institute of Neurology, Queen Square, London, UK.
Helgi B SchiöthDepartment of Neuroscience, Uppsala University, Uppsala, Sweden.
Uppsala University · SESahlgrenska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesTo investigate whether total sleep deprivation (TSD) affects circulating concentrations of neuron-specific enolase (NSE) and S100 calcium binding protein B (S-100B) in humans. These factors are usually found in the cytoplasm of neurons and glia cells. Increasing concentrations of these factors in blood may be therefore indicative for either neuronal damage, impaired blood brain barrier function, or both. In addition, amyloid β (Aβ) peptides 1-42 and 1-40 were measured in plasma to calculate their ratio. A reduced plasma ratio of Aβ peptides 1-42 to 1-40 is considered an indirect measure of increased deposition of Aβ 1-42 peptide in the brain.

designSubjects participated in two conditions (including either 8-h of nocturnal sleep [22:30-06:30] or TSD). Fasting blood samples were drawn before and after sleep interventions (19:30 and 07:30, respectively).

settingSleep laboratory.

participants15 healthy young men.

resultsTSD increased morning serum levels of NSE (P = 0.002) and S-100B (P = 0.02) by approximately 20%, compared with values obtained after a night of sleep. In contrast, the ratio of Aβ peptides 1-42 to 1-40 did not differ between the sleep interventions.

conclusionsFuture studies in which both serum and cerebrospinal fluid are sampled after sleep loss should elucidate whether the increase in serum neuron-specific enolase and S100 calcium binding protein B is primarily caused by neuronal damage, impaired blood brain barrier function, or is just a consequence of increased gene expression in non-neuronal cells, such as leukocytes.

Indexed as

Acute DiseaseAmyloid beta-PeptidesFastingHealthy VolunteersHumansMalePeptide FragmentsPhosphopyruvate HydrataseS100 ProteinsSleepSleep DeprivationTime FactorsYoung AdultAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Peptide FragmentsPhosphopyruvate HydrataseS100 Proteinsamyloid betaneuron-specific enolaseS100 calcium binding protein BsleepSleep loss

Identifiers

PMID24470708
PMCPMC3902870
OpenAlexW1998461449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.